Table 5: Distribution of major SCCmec and pulsotypes among MRSA isolates according to antibiotic resistant phenotype.

Antibiotic Resistant Phenotypes No. (%) Major SCCmec Types No. (%) Major PulsotypesNo. (%)
I II III IV N 1 6 12 15 31
CefoxitinC 36(100) 9(25) 10(27) 7(19.4) 6(16.6) 4(11.1) 4(12.1) 6(18.1) 1(3) 6(18.1) 2(6)
Gentamicin 30(83.3) 9(25) 7(19.4) 7(19.4) 5(13.8) 2(5.5) 3(9) 6(18.1) 1(3) 5(15.1) 1(3)
Erythromycin 30(83.3) 8(22.2) 7(19.4) 6(16.6) 5(13.8) 4(11.1) 3(9) 6(18.1) 0(0) 5(15.1) 0(0)
Doxycycline 12(33.3) 3(8.3) 2(5.5) 4(11.1) 1(2.7) 2(5.5) 1(3) 2(6) 0(0) 3(9) 0(0)
Minocycline 5(13.8) 3(8.3) 1(2.7) 1(2.7) 0(0) 0(0) 1(3) 2(6) 0(0) 2(6) 0(0)
Ciprofloxacin 11(30.5) 5(13.8) 3(8.3) 2(5.5) 1(2.7) 0(0) 3(9) 2(6) 1(3) 1(3) 0(0)
Clindamycin 19(52.7) 5(13.8) 3(8.3) 6(16.6) 3(8.3) 2(5.5) 3(9) 3(9) 1(3) 2(6) 1(3)
Trimethoprim 14(38.8) 3(8.3) 2(5.5) 3(8.3) 4(11.1) 2(5.5) 2(6) 2(6) 1(3) 2(6) 1(3)
Rifampin 13(36.1) 6(16.6) 2(5.5) 4(11.1) 0(0) 1(2.7) 1(3) 2(6) 1(3) 1(3) 1(3)
Quinupristindalfopristin 1(2.7) 0(0) 0() 0(0) 0(0) 1(2.7) 0(0) 0(0) 0(0) 1(3) 0(0)
Linezolid 1(2.7) 0(0) 0() 1(2.7) 0(0) 0(0) 0(0) 0(0) 0(0) 0(0) 1(3)